Measuring disease activity in Crohn's disease

Area of Science:

• Gastroenterology and Hepatology
• Inflammatory Bowel Disease Research

Background:

• Crohn's disease (CD) management has evolved with new therapies, but predicting disease outcomes and subclinical relapse remains a significant challenge.
• Current assessment relies on disease behavior, clinical-endoscopic activity, and intestinal damage, with mucosal healing proposed as a therapeutic goal.

Purpose of the Study:

• To address the limitations in predicting CD outcomes and relapse.
• To explore advanced imaging techniques for evaluating both luminal and extraluminal intestinal damage in Crohn's disease.

Main Methods:

• Review of recent advancements in therapeutic agents for severe Crohn's disease.
• Evaluation of proposed variables for predicting disease outcome, including disease behavior and clinical-endoscopic activity.
• Exploration of novel imaging techniques such as ultrasonography, computed tomography, and magnetic resonance imaging for assessing transmural disease.

Main Results:

• Introduction of novel therapeutic agents has expanded treatment options for severe Crohn's disease.
• Mucosal healing is a proposed therapeutic goal, but its role in transmural disease requires further definition.
• Advanced imaging techniques are emerging as crucial tools for evaluating comprehensive intestinal damage.

Conclusions:

• Predicting Crohn's disease outcomes and subclinical relapse remains a critical unmet need.
• Advanced imaging modalities are essential for a comprehensive assessment of intestinal damage in Crohn's disease.
• Further research is needed to integrate these imaging techniques into routine clinical practice for improved patient management.